The global Anti-Biofilm Wound Dressing Market is estimated to be valued at US$ 734.0 Mn in 2023 and is expected to exhibit a CAGR of 13.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Anti-biofilm wound dressings are specially designed dressings that help in removal and prevention of bacterial biofilm formation on acute and chronic wounds. These dressings form a protective barrier over the wound bed and facilitate wound healing process by maintaining a moist environment for tissue regeneration.
Market key trends:
Rise in chronic wounds such as diabetic foot ulcers, pressure ulcers and venous leg ulcers due to increasing geriatric population and growing prevalence of lifestyle diseases is a major factor driving growth of the global anti-biofilm wound dressing market. According to American Diabetes Association, in 2020, approximately 34.2 million Americans suffered from diabetes. Untreated chronic wounds can lead to severe infections and even amputation in diabetics. Anti-biofilm wound dressings help in active removal of biofilm and faster wound closure in chronic cases. Similarly, increasing number of surgical procedures and road accidents have also led to growth in acute wound incidence rate thus boosting demand for improved wound management products.
Segment Analysis
The global anti-biofilm wound dressing market is segmented based on product type, wound type, end-user, and geography. By product type, the silver-based wound dressings segment held the largest share in 2023 owing to the intrinsic antimicrobial properties of silver. Silver-based wound dressings are effective against various pathogens and fungi and help in preventing wound infection.
Key Takeaways
The Global Anti-Biofilm Wound Dressing Market Size is expected to reach US$ 1,521.3 Mn by 2030, expanding at a CAGR of 13.5% during the forecast period. Increasing prevalence of chronic wounds such as diabetic foot ulcers and pressure ulcers globally is expected to drive market revenue growth.
Regionally, North America dominated the global market in 2023 and is expected to maintain its dominance over the forecast period. High awareness regarding advanced wound care products and robust healthcare infrastructure are factors attributable to the region's large market share.
Key players operating in the anti-biofilm wound dressing market are 3M, Convatec Group PLC, Smith & Nephew PLC, Urgo Medical, and Coloplast Corporation, among others. 3M dominates the market and offers a wide range of antimicrobial wound dressings such as Tegaderm and Adaptic. The company focuses on new product launches and expansion strategies to further strengthen its market position.
Get More Insights Here